公司资料
Lipella Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- LIPO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月24日
—
市值
股价为何变动
Current closing-price context is not available for LIPO.
公司概览
业务概览
Lipella Pharmaceuticals is a specialty pharmaceutical company focused on localized therapies for difficult urologic and inflammatory conditions. Its story is built around reformulating existing drugs for targeted delivery.
所在地与行业分类
Lipella is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and drug-delivery development.
商业模式特征
The company depends on clinical development, regulatory progress, and the ability to create value through localized formulations. Investors usually watch data updates and pipeline execution.
生物医药行业定位
Lipella occupies a narrow specialty-pharma niche within biotech. It is a formulation story where better delivery could matter as much as the active ingredient.
未来催化剂
- Lipella’s catalysts are intravesical and mucosal-delivery programs, especially any clinical update that keeps the pipeline credible. The company still needs human proof.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。